Topics
CME/CE
Editorial Board
Importance of Clinical Trial Data, Disease Control, and QoL in Atopic Dermatitis Management
Raj Chovatiya, M.D., Ph.D. and Neal Bhatia, MD comment on the importance of assessing a treatment’s available clinical trial data, ability to control disease severity, and QoL impacts when assessing atopic dermatitis treatment options.
EP: 1.Expert Perspectives on the Rapid Expansion of Atopic Dermatitis Treatments
EP: 2.Atopic Dermatitis Treatment Biological Targets
EP: 3.Use of JAK Inhibitors in Clinical Practice
Now Viewing
EP: 4.Importance of Clinical Trial Data, Disease Control, and QoL in Atopic Dermatitis Management
EP: 5.Final Thoughts for Atopic Dermatitis Treatment
EP: 6.Expert Perspective on the Care of Patients with Atopic Dermatitis
EP: 7.Role of Disease Severity in Topical vs Systemic AD Treatment
EP: 8.Efficacy and Safety of JAK inhibitors for AD
EP: 9.Optimizing Patient Outcomes with JAK Inhibitors
Related Videos
Related Content
